EE+ POEM Archive
Continuing olanzapine plus sertraline compared with sertraline alone reduces risk of relapse with psychotic depression
Continuing olanzapine plus sertraline compared with sertraline alone reduces risk of relapse with psychotic depression is a topic covered in the EE+ POEM Archive.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Continuing Olanzapine Plus Sertraline Compared With Sertraline Alone Reduces Risk of Relapse With Psychotic Depression." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314891/all/Continuing_olanzapine_plus_sertraline_compared_with_sertraline_alone_reduces_risk_of_relapse_with_psychotic_depression.
Continuing olanzapine plus sertraline compared with sertraline alone reduces risk of relapse with psychotic depression. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314891/all/Continuing_olanzapine_plus_sertraline_compared_with_sertraline_alone_reduces_risk_of_relapse_with_psychotic_depression. Accessed March 27, 2023.
Continuing olanzapine plus sertraline compared with sertraline alone reduces risk of relapse with psychotic depression. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314891/all/Continuing_olanzapine_plus_sertraline_compared_with_sertraline_alone_reduces_risk_of_relapse_with_psychotic_depression
Continuing Olanzapine Plus Sertraline Compared With Sertraline Alone Reduces Risk of Relapse With Psychotic Depression [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2023 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314891/all/Continuing_olanzapine_plus_sertraline_compared_with_sertraline_alone_reduces_risk_of_relapse_with_psychotic_depression.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Continuing olanzapine plus sertraline compared with sertraline alone reduces risk of relapse with psychotic depression
ID - 1314891
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314891/all/Continuing_olanzapine_plus_sertraline_compared_with_sertraline_alone_reduces_risk_of_relapse_with_psychotic_depression
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
